Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
CONCLUSIONS: All together, our results suggest sterile inflammation as a novel paradigm to disease progression, and we identify, for the first time, monocytes as a viable candidate for targeted therapy in MVD.
PMID: 31928435 [PubMed - in process]
Source: Circulation - Category: Cardiology Authors: Kim AJ, Xu N, Umeyama K, Hulin A, Ponny SR, Vagnozzi RJ, Green EA, Hanson P, McManus BM, Nagashima H, Yutzey KE Tags: Circulation Source Type: research
More News: Cardiology | Genetics | Heart | Heart Valve Disease | Heart Valves | Marfan Syndrome | Transplants